Dr. Reddy's Laboratories Ltd. NSE: DRREDDY | BSE: 500124

Mid-range Performer

In 4 Starfolio Baskets

Download real time

1249.30 1.30 (0.10%)

1.2M

NSE+BSE Volume

NSE 27 Nov, 2025 3:31 PM (IST)

Regulatory Approval

Dr Reddy's gets EU approval for AVT03, a biosimilar to Prolia, with a market size of $1.2 bn See details

Dr. Reddy's Laboratories Ltd. News and Updates

Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 1
Author: Geojit BNP Paribas

Keep track of all breaking news on Dr. Reddy's Laboratories Ltd. from all sources in a single place.

Load latest

Is Dr. Reddy's Laboratories Ltd. worth buying?

536 Votes:

Buy 77.8%

Sell 12.69%

Hold 9.51%

RESEARCH REPORTS

Sell SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf